IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 119 filers reported holding IMMUNITYBIO INC in Q1 2021. The put-call ratio across all filers is 2.09 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,596,110 | -40.5% | 2,719,592 | -2.1% | 0.00% | – |
| Q2 2023 | $7,720,716 | +60.1% | 2,777,236 | +4.8% | 0.00% | – |
| Q1 2023 | $4,822,660 | -92.9% | 2,649,813 | -80.3% | 0.00% | -100.0% |
| Q4 2022 | $68,303,558 | +106.7% | 13,472,102 | +102.6% | 0.00% | 0.0% |
| Q3 2022 | $33,047,000 | +375.4% | 6,649,331 | +255.9% | 0.00% | – |
| Q2 2022 | $6,951,000 | -81.7% | 1,868,524 | -72.4% | 0.00% | -100.0% |
| Q1 2022 | $37,925,000 | +0.4% | 6,760,306 | +8.8% | 0.00% | 0.0% |
| Q4 2021 | $37,789,000 | -27.0% | 6,215,377 | +16.9% | 0.00% | -33.3% |
| Q3 2021 | $51,795,000 | -13.5% | 5,317,780 | +26.8% | 0.00% | 0.0% |
| Q2 2021 | $59,885,000 | +8.1% | 4,193,620 | +79.8% | 0.00% | 0.0% |
| Q1 2021 | $55,375,000 | – | 2,332,572 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 251,556 | $1,387,000 | 1.70% |
| ORACLE INVESTMENT MANAGEMENT INC | 315,322 | $1,567,000 | 0.89% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,668,000 | 0.54% |
| ALLEN HOLDING INC /NY | 687,571 | $3,417,000 | 0.54% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $479,000 | 0.21% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $1,033,000 | 0.17% |
| Clearwater Capital Advisors, LLC | 185,911 | $924,000 | 0.13% |
| WEALTH EFFECTS LLC | 28,500 | $142,000 | 0.09% |
| Virtus ETF Advisers LLC | 35,048 | $174,000 | 0.07% |
| Vident Investment Advisory, LLC | 195,127 | $969,000 | 0.03% |